The global Cancer Biologics Market is estimated to be valued at US$ 94.5 Bn in 2023 and is expected to exhibit a CAGR of 7.7%
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |